国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Pyrococcus horikoshii 50S ribosomal protein L14P (rpl14p) CSB-YP528858FHX
CSB-EP528858FHX
CSB-BP528858FHX
CSB-MP528858FHX
CSB-EP528858FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus horikoshii 50S ribosomal protein L32e (rpl32e) CSB-YP528859FHX
CSB-EP528859FHX
CSB-BP528859FHX
CSB-MP528859FHX
CSB-EP528859FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus horikoshii GTP cyclohydrolase mptA (mptA) CSB-YP528860FHX
CSB-EP528860FHX
CSB-BP528860FHX
CSB-MP528860FHX
CSB-EP528860FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus horikoshii Putative ABC transporter ATP-binding protein PH1815 (PH1815) CSB-YP528861FHX
CSB-EP528861FHX
CSB-BP528861FHX
CSB-MP528861FHX
CSB-EP528861FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus horikoshii UPF0278 protein PH1839 (PH1839) CSB-YP528862FHX
CSB-EP528862FHX
CSB-BP528862FHX
CSB-MP528862FHX
CSB-EP528862FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus horikoshii Ribonuclease P protein component 3 (rnp3) CSB-YP528863FHX
CSB-EP528863FHX
CSB-BP528863FHX
CSB-MP528863FHX
CSB-EP528863FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pyrococcus horikoshii DNA polymerase (pol) CSB-YP528864FHX
CSB-EP528864FHX
CSB-BP528864FHX
CSB-MP528864FHX
CSB-EP528864FHX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant DNA-binding protein 7b (ssh7b) CSB-YP528865FPJ
CSB-EP528865FPJ
CSB-BP528865FPJ
CSB-MP528865FPJ
CSB-EP528865FPJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Histidine biosynthesis bifunctional protein his7 (his7) CSB-YP528866SXV
CSB-EP528866SXV
CSB-BP528866SXV
CSB-MP528866SXV
CSB-EP528866SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe ATP synthase subunit H, mitochondrial (atp14) CSB-YP528867SXV
CSB-EP528867SXV
CSB-BP528867SXV
CSB-MP528867SXV
CSB-EP528867SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C18E5.01 (SPBC18E5.01, SPBC29A3.19) CSB-YP528868SXV
CSB-EP528868SXV
CSB-BP528868SXV
CSB-MP528868SXV
CSB-EP528868SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized protein C36.11 (SPBC36.11), partial CSB-YP528869SXV1
CSB-EP528869SXV1
CSB-BP528869SXV1
CSB-MP528869SXV1
CSB-EP528869SXV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Dihydroceramide delta (4)-desaturase, partial CSB-YP528870SXV1
CSB-EP528870SXV1
CSB-BP528870SXV1
CSB-MP528870SXV1
CSB-EP528870SXV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Formation of crista junctions protein C3E7.05c (SPBC3E7.05c), partial CSB-YP528871SXV1
CSB-EP528871SXV1
CSB-BP528871SXV1
CSB-MP528871SXV1
CSB-EP528871SXV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized J domain-containing protein C3E7.11c (SPBC3E7.11c) CSB-YP528872SXV
CSB-EP528872SXV
CSB-BP528872SXV
CSB-MP528872SXV
CSB-EP528872SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe BAG family molecular chaperone regulator 1B (bag102) CSB-YP528873SXV
CSB-EP528873SXV
CSB-BP528873SXV
CSB-MP528873SXV
CSB-EP528873SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized transcriptional regulatory protein C530.08 (SPBC530.08), partial CSB-YP528874SXV
CSB-EP528874SXV
CSB-BP528874SXV
CSB-MP528874SXV
CSB-EP528874SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Kinesin-like protein 6 (klp6), partial CSB-YP528875SXV
CSB-EP528875SXV
CSB-BP528875SXV
CSB-MP528875SXV
CSB-EP528875SXV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized metal transporter C1020.03 (SPCC1020.03), partial CSB-YP528876SXV1
CSB-EP528876SXV1
CSB-BP528876SXV1
CSB-MP528876SXV1
CSB-EP528876SXV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Schizosaccharomyces pombe Uncharacterized membrane protein C1020.11c (SPCC1020.11c), partial CSB-YP528877SXV1
CSB-EP528877SXV1
CSB-BP528877SXV1
CSB-MP528877SXV1
CSB-EP528877SXV1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產(chǎn)重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗總結出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質(zhì)合成機制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達載體可使外源基因在宿主細胞中高效表達,經(jīng)過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標題所示,本文主要總結了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價格、交貨、質(zhì)量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>